Alain Patrick Algazi (Alain Algazi, Alain P Algazi)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Squamous Cell Carcinoma

Advanced Non Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Pigment cell & melanoma research

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Arushi Gulati, Karolina A Plonowska, Erika M Stephens, Sagar Kansara, Aaron L Zebolsky, Edgar Ochoa, Mary Jue Xu, Patrick K Ha, Chase M Heaton, Sue S Yom, Jason W Chan, Alain Patrick Algazi, Hyunseok Kang, William R Ryan
A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2023)
Hani M Babiker, Erkut Hasan Borazanci, Vivek Subbiah, Sanjiv Agarwala, Alain Patrick Algazi, Jacob Schachter, Michael Lotem, Corinne Maurice-Dror, Daniel Hendler, Shah Rahimian, Hans Minderman, Cara L Haymaker, Daruka Mahadevan, Chantale Bernatchez, Ravi Murthy, Rolf Hultsch, Nadia Kaplan, Gregory Woodhead, Charles Hennemeyer, Srinivas Chunduru, Peter M Anderson, Adi Diab, Igor Puzanov
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Mia Han, Bianca Nguyen, Jack Y Lee, Erica Browning, Jun Zhang, Anandaroop Mukhopadhyay, Ravindra Gujar, Jon Salazar, Reneta Hermiz, Lauren Svenson, Annah S Rolig, William L Redmond, Alain Patrick Algazi, Adil I Daud, David A Canton, Christopher G Twitty
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity. Molecular cancer research : MCR 20 (6) (2022)
Charu Aggarwal, Nabil F Saba, Alain Patrick Algazi, Ammar Sukari, Tanguy Y Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T Esser, Lily I Cheng, Sonia Agrawal, Emily C Jennings, Nicholas M Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gasco Hernandez, Rakesh Kumar
Safety and Efficacy of MEDI0457 Plus Durvalumab in Patients With Human Papillomavirus-associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ezra E W Cohen, Lisle Nabell, Deborah J Wong, Terry A Day, Gregory A Daniels, Mohammed Milhem, Sanjeev Deva, Michael B Jameson, Orlando Guntinas-Lichius, Mohammed Almubarak, Matthew Strother, Eric D Whitman, Michael Chisamore, Cynthia Obiozor, Teresa Bagulho, Jose Gomez-Romo, Cristiana Guiducci, Robert Janssen, Erick Gamelin, Alain Patrick Algazi
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (6) (2022)
Antoni Ribas, Alain Patrick Algazi, Paolo Antonio Ascierto, Marcus O Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H Miller, Katie M Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature communications 12 (1) (2021)
Matthew H Taylor, Courtney B Betts, Lauren Maloney, Eric Nadler, Alain Patrick Algazi, Michael J Guarino, John J Nemunaitis, Antonio Jimeno, Priti Patel, Veerendra Munugalavadla, Lin Tao, Douglas Adkins, Jerome H Goldschmidt, Ezra E W Cohen, Lisa M Coussens
Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Alain Patrick Algazi, Megan K D Othus, Adil I Daud, Roger S Lo, Janice M Mehnert, Thach-Giao Truong, Robert Conry, Kari Kendra, Gary C Doolittle, Joseph I Clark, Michael J Messino, Dennis F Moore, Christopher Lao, Bryan A Faller, Rangaswamy Govindarajan, Amy Harker-Murray, Luke Dreisbach, James Moon, Kenneth F Grossmann, Antoni Ribas
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial. Nature medicine 26 (10) (2020)
Antoni Ribas, Alain Patrick Algazi, Paolo Antonio Ascierto, Marcus O Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H Miller, Katie M Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature communications 11 (1) (2020)
Alain Patrick Algazi, Julia Rotow, Christian Posch, Susana Ortiz-Urda, Alyson Pelayo, Pamela N Munster, Adil Daud
A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600E/K mutant advanced melanoma. Pigment cell & melanoma research 32 (4) (2019)
Alain Patrick Algazi, Rosaura Esteve-Puig, Adi Nosrati, Brian Hinds, Adele Hobbs-Muthukumar, Prachi Nandoskar, Susana Ortiz-Urda, Paul B Chapman, Adil Daud
Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma. Pigment cell & melanoma research 31 (1) (2017)